Terminated NCT01127646
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Arnhem Why is this study shown? This study is directly about ADHD.
ADHD Drug i A study involving a medication or substance. From 6 Years to 16 Years
Countries Netherlands, Spain, Sweden
Sponsor Eli Lilly and Company
Condition ADHD Completed NCT00564954
This study is completed in the United States. It is testing Dex-methylphenidate Extended Release for ADHD.
Multiple locations, including Little Rock Why is this study shown? This study is directly about ADHD.
ADHD Drug From 6 Years to 12 Years
Countries United States
Sponsor Novartis Pharmaceuticals
Condition ADHD Completed NCT00922636
This study is completed in the United States and in Canada. It focuses on ADHD.
Multiple locations, including Spring Valley Why is this study shown? This study is directly about ADHD.
ADHD Drug From 6 Years to 17 Years
Countries United States, Canada
Sponsor Eli Lilly and Company
Condition ADHD Completed NCT00880217
This study is completed in the United States. It is testing 3 Different Doses of JNJ-31001074 for ADHD.
Multiple locations, including Little Rock Why is this study shown? This study is directly about ADHD.
ADHD Drug From 18 Years to 55 Years
Countries United States
Sponsor Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition ADHD Completed NCT00890292
This study is completed. It is testing Pharmacokinetics, Safety and Tolerability After a Single Dose Administration of JNJ-31001074 for ADHD.
Location not clearly listed Why is this study shown? This study is directly about ADHD.
ADHD Drug From 12 Years to 17 Years
Countries
Sponsor Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition ADHD Completed NCT00890240
This study is completed. It is testing Pharmacokinetics, Safety and Tolerability After a Single Dose Administration of of JNJ-31001074 for ADHD.
Location not clearly listed Why is this study shown? This study is directly about ADHD.
ADHD Drug From 6 Years to 11 Years
Countries
Sponsor Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition ADHD Completed NCT07001475
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Berlin Why is this study shown? This study is directly about ADHD.
ADHD Drug From 18 Years to 45 Years
Countries Germany
Sponsor Boehringer Ingelheim
Condition ADHD Completed NCT05588713
This summary needs review. Please check the official study record and contact the research team for details.
In Uppsala Why is this study shown? This study is directly about ADHD.
ADHD Other From 8 Years to 17 Years
Countries Sweden
Sponsor Uppsala University
Condition ADHD Completed NCT05279313
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Dothan Why is this study shown? This study is directly about ADHD.
ADHD Drug From 4 Years to 18 Years
Countries United States, Canada
Sponsor Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition ADHD Completed NCT00956605
This summary needs review. Please check the official study record and contact the research team for details.
In Boston Why is this study shown? This study is directly about ADHD.
ADHD Behavioral From 10 Years to 15 Years
Countries United States
Sponsor Tufts Medical Center
Condition ADHD Completed NCT04786730
This study is completed in the United States. It focuses on ADHD.
Multiple locations, including Little Rock Why is this study shown? This study is directly about ADHD.
ADHD Drug From 4 Years to 12 Years
Countries United States
Sponsor Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition ADHD Completed NCT04398225
This summary needs review. Please check the official study record and contact the research team for details.
In Hollywood Why is this study shown? This study is directly about ADHD.
ADHD Drug From 4 Years to 12 Years
Countries United States
Sponsor Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition ADHD